BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16774486)

  • 1. Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139.
    Ahmed MH; Saad RA; Osman MM
    Expert Opin Drug Saf; 2006 Jul; 5(4):487-8. PubMed ID: 16774486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease].
    Abel T; Fehér J; Dinya E; Gamal Eldin M; Kovács A
    Orv Hetil; 2009 May; 150(21):989-93. PubMed ID: 19443308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe combines with simvastatin to tackle cholesterol. New drugs attack "bad" cholesterol in the liver and intestine.
    Heart Advis; 2007 Jul; 10(7):7. PubMed ID: 17695657
    [No Abstract]   [Full Text] [Related]  

  • 4. Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.
    Gryn SE; Hegele RA
    Expert Opin Pharmacother; 2015 Jun; 16(8):1255-62. PubMed ID: 25920750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol drug controversy continues.
    Mitka M
    JAMA; 2008 May; 299(19):2266. PubMed ID: 18492963
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia.
    Krysiak R; Zmuda W; Okopien B
    Cardiovasc Ther; 2014 Apr; 32(2):40-6. PubMed ID: 24354929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.
    Galin ID; Smith DA
    Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302
    [No Abstract]   [Full Text] [Related]  

  • 8. Amid lingering questions, FDA reprieves LDL cholesterol-lowering medication.
    Mitka M
    JAMA; 2009 Feb; 301(8):813-5. PubMed ID: 19244181
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treats two sources of cholesterol.
    Nurse Pract; 2005 Mar; 30(3):70. PubMed ID: 15753829
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
    Davidson MH
    J Am Coll Cardiol; 2003 Jul; 42(2):398-9; author reply 399. PubMed ID: 12875794
    [No Abstract]   [Full Text] [Related]  

  • 11. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
    Derosa G; D'Angelo A; Franzetti IG; Ragonesi PD; Gadaleta G; Scalise F; Ciccarelli L; Piccinni MN; Cicero AF
    J Clin Pharm Ther; 2009 Jun; 34(3):267-76. PubMed ID: 19650249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin/ezetimibe combination therapy: emerging evidence.
    Kalhan A; Rees A
    Curr Opin Lipidol; 2011 Apr; 22(2):146-7. PubMed ID: 21415606
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.
    Ahmed MH; Byrne CD
    Diabetes Obes Metab; 2010 Nov; 12(11):958-66. PubMed ID: 20880342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
    Davidson MH
    Cleve Clin J Med; 2008 Jul; 75(7):479-82, 486-8, 490-1. PubMed ID: 18646584
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
    Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA; Kaul S
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Schunn H
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2202; author reply 2202. PubMed ID: 20979010
    [No Abstract]   [Full Text] [Related]  

  • 20. Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemia.
    Murdoch D; Scott LJ
    Am J Cardiovasc Drugs; 2004; 4(6):405-22. PubMed ID: 15554726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.